High glucose stimulates GRO secretion from rat microglia via ROS 5 PKC, and NF-κB pathways

Journal of Neuroscience Research

Volumn 85, Issue 14, 2007, Pages 3150-3159

  Quan, Yi ^a   Du, Jianhai ^b   Wang, Xian ^a,b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

GRO; High glucose; Microglia; NF B; PKC; ROS

Indexed keywords

ACETYLCYSTEINE; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CALPHOSTIN C; CHELERYTHRINE; CHEMOKINE; GROWTH REGULATED ONCOGENE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MELANOMA GROWTH STIMULATORY ACTIVITY FACTOR; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; PYRROLIDINE DITHIOCARBAMATE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ANALYSIS; HYPERGLYCEMIA; MICROGLIA; NERVE CELL LESION; NONHUMAN; OSMOLALITY; PATHOGENESIS; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; CHEMOKINE CXCL1; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUCOSE; MICROGLIA; PROTEIN KINASE C; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; TIME FACTORS;

EID: 35848968007     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21421     Document Type: Article

References (53)

1. Aarum J, Sandberg K, Haeberlein SL, Persson MA. 2003. Migration and differentiation of neural precursor cells can be directed by microglia. Proc Natl Acad Sci 100:15983-15988.
2. Atanassov CL, Muller CD, Dumont S, Rebel G, Poindron P, Seiler N. 1995. Effect of ammonia on endocytosis and cytokine production by immortalized human microglia and astroglia cells. Neurochem Int 27:417-424.
3. Bian ZM, Elner SG, Strieter RM, Glass MB, Lukacs NW, Kunkel SL, Elner VM. 1996. Glycated serum albumin induces chemokine gene expression in human retinal pigment epithelial cells. J Leukoc Biol 60:405-414.
4. Brat DJ, Bellail AC, Van Meir EG. 2005. The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro-oncol 7:122-133.
5. Brownlee M. 2001. Biochemistry and molecular cell biology of diabetic complications. Nature 414:813-820.
6. Ceriello A, Quatraro A, Giugliano D. 1993. Diabetes mellitus and hypertension: the possible role of hyperglycaernia through oxidative stress. Diabetologia 36:265-266.
7. Chu S, Bohlen HG. 2004. High concentration of glucose inhibits glomerular endothelial eNOS through a PKC mechanism. Am J Physiol Renal Physiol 287:F384-F392.
8. Curtis TM, Scholfield CN. 2004. The role of lipids and protein kinase Cs in the pathogenesis of diabetic retinopathy. Diabetes Metab Res Rev 20:28-43.
9. Du Y, Miller CM, Kern TS. 2003. Hyperglycemia increases mitochondrial superoxide in retina and retinal cells. Free Radic Biol Med 35:1491-1499.
10. Festa A, D'Agostino R, Howard G, Mykkanen L, Tracy RP, Haffner SM. 2000. Chronic subclinical inflammation as part of the insulin resistance syndrome. Circulation 102:42-47.
11. Franciosi S, Choi HB, Kim SU, McLarnon JG. 2005. IL-8 enhancement of amyloid-beta (Abeta 1-42)-induced expression and production of pro-inflammatory cytokines and COX-2 in cultured human microglia. J Neuroimmunol 159:66-74.
12. Ginzinger DG. 2002. Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. Exp Hematol 30:503-512.
13. Hesselgesser J, Horuk R. 1999. Chemokine and chemokine receptor expression in the central nervous system. J Neurovirol 5:13-26.
14. Kim SU, de Vellis J. 2005. Microglia in health and disease. J Neurosci Res 81:302-313.
15. Klein JP, Hains BC, Craner MJ, Black JA, Waxman SG. 2004. Apoptosis of vasopressinergic hypothalamic neurons in chronic diabetes mellitus. Neurobiol Dis 15:221-228.
16. Knudsen GM, Jakobsen J, Barry DI, Compton AM, Tomlinson DR. 1989. Myo-inositol normalizes decreased sodium permeability of the blood-brain barrier in streptozotocin diabetes. Neuroscience 29:773-777.
17. Konishi K, Takata Y, Yamamoto M, Yomogida K, Watanabe K, Tsurufuji S, Fujioka M. 1993. Structure of the gene encoding rat neutrophil chemo-attractant Gro. Gene 126:285-286.
18. Kouroedov A, Eto M, Joch H, Volpe M, Luscher TF, Cosentino F. 2004. Selective inhibition of protein kinase Cbeta2 prevents acute effects of high glucose on vascular cell adhesion molecule-1 expression in human endothelial cells. Circulation 110:91-96.
19. Kreutzberg G. 1996. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19:312-318.
20. Larsen CG, Anderson AO, Appella E, Oppenheim JJ, Matsushima K. 1989. The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 243:1464-1466.
21. Lee YB, Nagai A, Kim SU. 2002. Cytokines, chemokines, and cytokine receptors in human microglia. J Neurosci Res 69:94-103.
22. Lee HB, Yu MR, Yang Y, Jiang Z, Ha H. 2003. Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. J Am Soc Nephrol 14:S241-S245.
23. Leonard EJ, Yoshimura T. 1990. Neutrophil attractant/activation protein-1 (NAP-1 [interleukin-8]). Am J Respir Cell Mol Biol 2:479-86.
24. Li ZG, Zhang W, Grunberger G, Sima AA. 2002. Hippocampal neuronal apoptosis in type 1 diabetes. Brain Res 946:221-231.
25. Li ZG, Zhang W, Sima AA. 2003. C-peptide enhances insulin-mediated cell growth and protection against high glucose-induced apoptosis in SH-SY5Y cells. Diabetes Metab Res Rev 19:375-85.
26. Li ZG, Sima AA. 2004. C-peptide and central nervous system complications in diabetes. Exp Diabesity Res 5:79-90.
27. Limatola C, Ciotti MT, Mercanti D, Santoni A, Eusebi F. 2002. Signaling pathways activated by chemokine receptor CXCR2 and AMPA-type glutamate receptors and involvement in granule cells survival. J Neuroimmunol 123:9-17.
28. Lindstrom TM, Bennett PR. 2005. The role of nuclear factor kappa B in human labour. Reproduction 130:569-581.
29. Makimattila S, Malmberg-Ceder K, Hakkinen AM, Vuori K, Salonen O, Summanen P, Yki-Jarvinen H, Kaste M, Heikkinen S, Lundbom N, Roine RO. 2004. Brain metabolic alterations in patients with type 1 diabetes-hyperglycemia- induced injury. J Cereb Blood Flow Metab 24: 1393-1399.
30. Mijnhout GS, Scheltens P, Diamant M, Biessels GJ, Wessels AM, Simsek S, Snoek FJ, Heine RJ. 2006. Diabetic encephalopathy: A concept in need of a definition. Diabetologia 49:1447-1448.
31. Miwa T, Furukawa S, Nakajima K, Furukawa Y, Kohsaka S. 1997. Lipopolysaccharide enhances synthesis of brain-derived neurotrophic factor in cultured rat microglia. J Neurosci Res 50:1023-1029.
32. Mochly-Rosen D. 1995. Localization of protein kinases by anchoring proteins: a theme in signal transduction. Science 268:247-251.
33. Park JY, Takahara N, Gabriele A, Chou E, Naruse K, Suzuma K, Yamauchi T, Ha SW, Meier M, Rhodes CJ, King GL. 2000. Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation. Diabetes 49:1239-1248.
34. Pomerantz JL, Baltimore D. 2002. Two pathways to NF-kappaB. Mol Cell 10:693-695.
35. Puma C, Danik M, Quirion R, Ramon F, Williams S. 2001. The chemokine interleukin-8 acutely reduces Ca(2+) currents in identified cholinergic septal neurons expressing CXCR1 and CXCR2 receptor mRNAs. J Neurochem 78:960-971.
36. Quagliaro L, Piconi L, Assaloni R, Martinelli L, Motz E, Ceriello A. 2003. Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation. Diabetes 52:2795-2804.
37. Rolo AP, Palmeira CM. 2006. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol 212:167-178.
38. Rosen P, Nawroth PP, King G, Moller W, Tritschler HJ, Packer L. 2001. The role f oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCOMCBN, the American Diabetes Association, and the German Diabetes Society. Diabetes Metab Res Rev 17:189-212.
39. Rungger-Brandle E, Dosso AA, Leuenberger PM. 2000. Glial reactivity, an early feature of diabetic retinopathy. Invest Ophthalmol Vis Sci 41:1971-1980.
40. Sima AA. 2003. New insights into the metabolic and molecular basis for diabetic neuropathy. Cell Mol Life Sci 60:2445-2464.
41. Sima AA, Kamiya H, Li ZG. 2004. Insulin, C-peptide, hyperglycemia, and central nervous system complications in diabetes. Eur J Pharmacol 490:187-197.
42. Sopper S, Demuth M, Stahl-Hennig C, Hunsmann G, Plesker R, Coulibaly C, Czub S, Ceska M, Koutsilieri E, Riederer P, Brinkmann R, Katz M, ter Meulen V. 1996. The effect of simian immunodeficiency virus infection in vitro and in vivo on the cytokine production of isolated microglia and peripheral macrophages from rhesus monkey. Virology 220:320-329.
43. Sredy J, Sawicki DR, Notvest RR. 1991. Polyol pathway activity in nervous tissues of diabetic and galactose-fed rats: effect of dietary galactose withdrawal or tolrestat intervention therapy. J Diabet Complications 5:42-47.
44. Srinivasan S, Bolick DT, Hatley ME, Natarajan R, Reilly KB, Yeh M, Chrestensen C, Sturgill TW, Hedrick CC. 2004. Glucose regulates interleukin-8 production in aortic endothelial cells through activation of the p38 mitogen-activated protein kinase pathway in diabetes. J Biol Chem 279:31930-31936.
45. Temaru R, Urakaze M, Satou A, Yamazaki K, Nakamura N, Kobayashi M. 1997. High glucose enhances the gene expression of interleukin-8 in human endothelial cells, but not in smooth muscle cells: possible role of interleukin-8 in diabetic macroangiopathy. Diabetologia 40:610-613.
46. Williams K, Bar-Or A, Ulvestad E, Olivier A, Antel JP, Yong VW. 1992. Biology of adult human microglia in culture: comparisons with peripheral blood monocytes and astrocytes. J Neuropathol Exp Neurol 51:538-549.
47. Vanderbilt JN, Mager EM, Allen L, Sawa T, Wiener-Kronish J, Gonzalez R, Dobbs LG. 2003. CXC chemokines and their receptors are expressed in type II cells and upregulated following lung injury. Am J Respir Cell Mol Biol 29:661-668.
48. Vilhardt F. 2005. Microglia: phagocyte and glia cell. Int J Biochem Cell Biol 37:17-21.
49. Walker DG, Link J, Lue LF, Dalsing-Hernandez JE, Boyes BE. 2006. Gene expression changes by amyloid beta peptide-stimulated human postmortem brain microglia identify activation of multiple inflammatory processes. J Leukoc Biol 79:596-610.
50. Xiong H, Boyle J, Winkelbauer M, Gorantla S, Zheng J, Ghorpade A, Persidsky Y, Carlson KA, Gendelman HE. 2003. Inhibition of long-term potentiation by interleukin-8: implications for human immunodeficiency virus-1-associated dementia. J Neurosci Res 71:600-607.
51. Yamasaki Y, Itoyama Y, Kogure K. 1996. Involvement of cytokine production in pathogenesis of transient cerebral ischemic damage. Keio J Med 45:225-229.
52. Zeiffer U, Schober A, Lietz M, Liehn EA, Erl W, Emans N, Yan ZQ, Weber C. 2004. Neointimal smooth muscle cells display a proinflammatory phenotype resulting in increased leukocyte recruitment mediated by P-selectin and chemokines. Circ Res 94:776-784.
53. Zozulinska D, Majchrzak A, Sobieska M, Wiktorowicz K and Wierusz-Wysocka B. 1999. Serum interleukin-8 level is increased in diabetic patients. Diabetologia 42:117-118.